Opisthotonos: A newly recognized side effect of midazolam

Journal of Pediatric Neurology

Volumn 2, Issue 1, 2004, Pages 49-

  Yilmaz, Deniz ^a   Sipahi, Tansu ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68849098396     PISSN: 13042580     EISSN: 13050613     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hanhan UA, Fiallos MR, Orlowski JP. Status epilepticus. Pediatr Clin North Am 2001; 48: 683-695.
2. Rey E, Treluyer JM, Pons G. Pharmakokinetic optimisation of benzodiazepine therapy for acute seizures. Clin Pharmacokinet 1999; 36: 409-424.
3. Waller D, Renwick A. Principles of Medical Pharmacology. London: Balliere Tindall, 1994.
4. World Health Organization. Symptom relief in terminal illness. Geneva: WHO, 1998.
5. Galbraith A, Bullock S, Manias E, Richards A, Hunt B. Fundamentals of Pharmacology: A Text for Nurses and Health Professionals. Singapore: Addison Wesley Longman, 1999.
6. Watanabe S, Satumae T, Takeshima R, Taguchi N. Opisthotonos after flumazenil administred to antagonize midazolam previously administered to treat developing local anesthetic toxicity. Anesth Analg 1998; 86: 677-678.